WHO says dexamethasone is a lifesaver for critically ill

WorldNews Wednesday, 17 June 2020 ()
WHO says dexamethasone is a lifesaver for critically illNEW DELHI : The World Health Organization (WHO) said on Wednesday that initial clinical trial results from Oxford University showed dexamethasone, a steroid, to be lifesaving for critically ill covid-19 patients. The acknowledgement of the breakthrough came as the number of covid cases in India touched 360,365 and deaths crossed 12,057. For patients on ventilators, the treatment was shown to reduce deaths by a third, and for patients requiring only oxygen, mortality was cut by about a fifth, according to preliminary findings shared with WHO. However, the benefit was only seen in patients seriously ill with covid-19, and was not observed in patients with milder...

You Might Like

💡 One News Page Knowledge: Other News Mentions

World Health Organization World Health Organization Specialized agency of the United Nations

WHO halts malaria drug in COVID-19 trials [Video]

WHO halts malaria drug in COVID-19 trials

The World Health Organization said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalized patients with COVID-19 after they failed to reduce mortality. This report produced by Jillian Kitchener.

Credit: Reuters Studio    Duration: 01:05Published

WHO lauds India's efforts in Covid-19 fight, says focus should be on data management

The World Health Organisation (WHO) has lauded India's efforts in tackling Covid-19 but said that the country should also focus on data management originating..

5 foods that help fight iron deficiency

The World Health Organization has shared a number of dietary tips and food recommendations that can help combat the problem of iron deficiency. ......

WHO asks South-East Asia region countries to pay attention to mental health, suicide prevention

With the coronavirus pandemic still accelerating, impacting lives and livelihoods and causing fear and anxiety among people, the World Health Organization on..

New Delhi New Delhi Capital of India

India-China tensions: Russia maintaining close touch with New Delhi, Beijing

Russia has, however, clearly said it will not mediate between China and India.

China weaponises data for spying, India has to stop Beijing's mobile apps, 5G invasion: Experts

The webinar was hosted on Friday evening by New Delhi-headquartered think-tank Law and Society Alliance and the Defence and Strategic Affairs news magazine..

TikTok distances from Beijing in response to India app ban

NEW DELHI: Social media app distanced itself from Beijing after India banned 59 Chinese apps in the country, according to a correspondence seen by Reuters. In a..

Japan backs India on LAC situation, opposes any change in status quo by China

Japan on Friday expressed hope for a peaceful resolution of the ongoing standoff between Indian and Chinese troops and asserted that it opposed any attempts to..

India’s Modi visits Himalayan border where troops clashed with China

NEW DELHI/SRINAGAR: Indian Prime Minister Narendra Modi flew into the northern Himalayan region of Ladakh on Friday, officials said, weeks after Indian...

Oxford University Police Oxford University Police

COVID-19: Human trial of new vaccine begins in UK

London:�Volunteers have begun being immunised with a new UK coronavirus vaccine. About 300 people will have the vaccine over the coming weeks, as part of a..
Malala Yousafzai Graduates Oxford University [Video]

Malala Yousafzai Graduates Oxford University

CNN reports that Malala Yousafzai, has graduated from Oxford University. She and her family celebrated, with cake and confetti. Malala, is a 22-year-old Nobel Peace Prize winner, who lived after being shot in the head at 15 by the Taliban. Born in Pakistan, Malala is an activist who speaks out about girls education and human rights. On Friday Malala tweeted, "Hard to express my joy and gratitude right now as I completed my Philosophy, Politics and Economics degree at Oxford.

Credit: Wochit News    Duration: 00:41Published
British protesters target symbols of slavery and empire [Video]

British protesters target symbols of slavery and empire

Protesters in Oxford demanded the removal of a statue of colonialist Cecil Rhodes, while in London, a slave-trader's statue was targeted as part of protests against symbols of the slave trade and empire.

Credit: Reuters Studio    Duration: 02:01Published
AstraZeneca to make billion COVID vaccine doses if tests succeed [Video]

AstraZeneca to make billion COVID vaccine doses if tests succeed

AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on Thursday it should shortly get results of an early stage clinical trial. Ciara Lee reports

Credit: Reuters Studio    Duration: 01:20Published
COVID-19 vaccine "won't be expensive", developer says [Video]

COVID-19 vaccine "won't be expensive", developer says

A keenly-watched COVID-19 vaccine will be priced to allow as wide as possible access to it, if it proves successful, and will be made at huge scale to keep costs down and supply up, said the Oxford University professor co-leading its development. Emer McCarthy reports.

Credit: Reuters Studio    Duration: 01:28Published

Related news from verified sources

Malaria drug touted by Trump fails to prevent COVID-19 in high profile study

Malaria drug touted by Trump fails to prevent COVID-19 in high profile study
By Michael Erman (Reuters) - The malaria drug promoted by U.S. President Donald Trump as a treatment for COVID-19 was ineffective in preventing infection in...
WorldNews Also reported by •Belfast TelegraphCBS News

Exclusive: Lonza sets new goal to make Moderna COVID-19 vaccine ingredients

Lonza aims to speed completion of two commercial production lines for Moderna Inc's trial COVID-19 vaccine so manufacturing could start four to six weeks earlier...
Reuters India Also reported by •RTTNewsCBS News

Revive Therapeutics holds pre-CTA meeting with Health Canada for Bucillamine to treat COVID-19 patients

Revive Therapeutics Ltd (CSE:RVV) (OTCMKTS:RVVTF), announced Tuesday that it held a Pre-Clinical Trial Application meeting with Health Canada to evaluate the...
Proactive Investors

Tweets about this